Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, Vivascience to Develop Protein Fractionation Kits for PerkinElmer Biomarker System

NEW YORK, Aug. 3 (GenomeWeb News) - PerkinElmer has signed onto a collaboration with Vivascience to create fractionation kits for proteomics-based biomarker analysis, the companies said today.


Under the agreement, the companies will combine PerkinElmer's elution chemistries with Vivascience's membrane adsorber chromatography technology to create the kits. PerkinElmer said it will then market these biomarker screening reagent kits along with its biomarker screening instruments, which include its Multiprobe II liquid handling workstation and proTOF 2000 MALDI-TOF mass spectrometer. The parties did not disclose the financial terms of the agreement.


PerkinElmer also said that Predictive Diagnostics, which recently began using PerkinElmer's proTOF for its clinical proteomics program, will have early access to the PerkinElmer/Vivascience fractionation kits through the end of the year.


Vivascience, of Hannover, Germany, produces chromatography technology that is rigid, unlike traditional resins and beads, the companies said.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.